Investors interested in AES Corp. stock should wait for a better entry point, considering its high debt value and dismal performance on the bourses.

Better pricing, product redesigns, technological advancements and improving inflation are expected to aid multiline insurers like MET, AIG, PFG, EG and AIZ.

KOD reports a wider-than-expected loss for the first quarter of 2025. The company provides updates regarding its pipeline development plans.

Among 16 U.S. banks with the strongest/most consistent earnings growth South Bend, Indiana--(Newsfile Corp. - May 15, 2025) - 1st Source (NASDAQ: SRCE) is pleased to announce that it made the annual Bank Honor Roll by Keefe, Bruyette & Woods, Inc. (KBW) for the seventh consecutive year. They are among just 16 U.S. Banks on the list, placing its long-term performance among the top 5% of eligible banks in the United States.

CoreWeave (NASDAQ:CRWV) shares moved higher after the AI cloud-computing startup reported significant revenue growth for the first quarter and raised its full-year outlook. First quarter revenue surged 420% year-over-year to $981.6 million, ahead of analyst expectations of $857 million.

Transaction in Own Shares 15 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 15 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 15/05/2025 775,325 £24.7700 £24.3950 £24.6030 LSE GBP 15/05/2025 233,104 £24.7700 £24.4000 £24.6055 Chi-X (CXE) GBP 15/05/2025 116,571 £24.7700 £24.4000 £24.6221 BATS (BXE) GBP 15/05/2025 703,629 €29.6050 €29.0900 …

MOS introduces Neptunion biostimulant product to the Chinese markets.

CE announces its intention to divest its Micromax portfolio as a part of its cash generation efforts.

ASBURY PARK, N.J.--(BUSINESS WIRE)--Solar Landscape, the nation's leading commercial rooftop solar developer, has announced a landmark $175 million long-term partnership with PGIM Private Capital, to finance its growing portfolio of projects that feed electricity directly into the distributed grid, initially across Maryland and Illinois. PGIM Private Capital is the private capital arm of PGIM, the $1.4 trillion global investment management business of Prudential Financial, Inc. (NYSE: PRU). The.

Kevin Hincks examines two mega-cap U.S. stocks in today's Daily Trader episode. For Tesla (TSLA), Kevin composes a long iron condor example, saying movement will dictate the bullish or bearish direction of the trade.

Driving Record, Age and Vehicle Type Are Major Considerations LOS ANGELES , May 15, 2025 /PRNewswire/ -- Prices for just about everything are on the rise these days, and unfortunately, that includes car insurance. Now more than ever, consumers are looking for ways to lower their auto insurance premiums.

LOS ANGELES , May 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Solaris Energy Infrastructure, Inc. ("Solaris" or the "Company") (NYSE: SEI). IF YOU SUFFERED A LOSS ON YOUR SOLARIS INVESTMENTS, CLICK HERE BEFORE MAY 27, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

LOS ANGELES , May 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Avis Budget Group, Inc. ("Avis" or the "Company") (NASDAQ: CAR). IF YOU SUFFERED A LOSS ON YOUR AVIS INVESTMENTS, CLICK HERE BEFORE JUNE 24, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 7, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) common stock between February 16, 2023 and February 12, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WEST PHARMACEUTICAL SERVICES, INC. (WST), CONTACT THE LAW OFFICES OF HOWARD G. S.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 1, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CIVITAS RESOURCES, INC. (CIVI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE.

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Prenuvo, a leader in proactive whole-body MRI screening, today announced the appointment of Jill Woodworth as Chief Financial Officer. A seasoned financial executive with deep experience leading high-growth companies through IPO and beyond, Woodworth will lead Prenuvo's financial strategy, operations, and long-term planning as the company enters its next phase of growth. Woodworth is best known for her role as Chief Financial Officer at Peloton, where she.

NEW YORK, NY / ACCESS Newswire / May 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive (the "Class Period"), of the important May 26, 2025 lead plaintiff deadline. SO WHAT: If you purchased Actinium securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Topline CATT1 Phase 3 data is expected in 2H 2026 Protocol amendment shortens trial duration from 12 to 6 months, expediting time to topline data HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead program in diabetes, today announced that screening has been reinitiated in the Company's CATT1 Phase 3 trial investigating cadisegliatin as an adjunctive treatment of type 1 diabetes (T1D).

NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Flowco Holdings Inc. ("Flowco Holdings Inc.") (NYSE:FLOC) concerning possible violations of federal securities laws. On May 13, 2025, Flowco issued a press release reporting its financial results for the first quarter of 2025.

LOS ANGELES , May 15, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Everus Construction Group, Inc. ("Everus" or the "Company") (NYSE: ECG). IF YOU SUFFERED A LOSS ON YOUR EVERUS INVESTMENTS, CLICK HERE BEFORE JUNE 3, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?